Robert Cook is a Head of Generics and SVP Global Small Molecule CMC and Combination Products at Teva Pharmaceuticals. He possess expertise in drug delivery, clinical development, pharmaceutical industry, r&d, formulation and 17 more skills. Colleagues describe him as "I had the privilege of working with Rob from 2005-2009 during his tenure at MAP Pharmaceuticals. I reported directly to Robert from 2007-2009, when he assume the role of Director, Research & Development. Robert is a very well-rounded pharmaceutical scientist with an excellent background in the inhalation sciences, aerosol sciences and pharmacology. This broad background enabled him to assume the very multifaceted role of Director, Research & Development for MAP Pharmaceuticals, which at the time was a small R&D based company with a variety of different development programs spanning the pre-clinical to Phase III areas. Robert was intimately involved in all programs at MAP, with particular emphasis on the early-stage development programs and for supporting the late stage R&D efforts for the Levadex platform. As a manager, Robert allowed me to work independently on several programs, while affording me opportunities to branch out and expand my skill set. He realized my strengths and geared my overall objectives towards areas where my skills would be best suited, but was flexible in allowing me to branch out into new areas that were of interest to me. He was very supportive of professional growth opportunities. As I was a very independent and analytical-type of worker, Robert never micro-managed me but always made himself available to me when needed. He was able to set realistic and achievable objectives for his staff that meshed with our company's overall corporate objectives.", "I worked with Rob on 2 separate occasions at MicroDose. Rob excelled in his role at MicroDose and was a results driven leader who continually challenges the status quo. He consistently rose the bar on the quality of deliverables for the projects he led. I would give Rob my highest recommendation and would gladly work with him again. Kent Mosier", and "Rob has incredibly broad knowledge of pharmaceutical and bio-pharmaceutical product development landscape and admirable talent for formulating new product ideas. I worked for Rob for 2 years at MAP and I found his passion and drive for developing new product pipeline both impressive and inspiring. In my opinion, Rob’s traits, interests and experience make him an ideal candidate for technical senior management position in a small to medium size company focused on pharmaceutical or biotechnological product development."